Ocugen reconvenes special shareholder meeting, adjourns vote on authorized share increase proposal

• Ocugen’s special stockholder meeting reconvened on Oct. 5, 2026, then adjourned again.
• Shareholders did not adopt an amendment to increase authorized common shares by 250,000,000; the vote was deferred.
• The meeting was adjourned to Oct. 26, 2026 to allow more time for consideration and voting on the share-authorisation increase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065077), on October 06, 2026, and is solely responsible for the information contained therein.